IDiyas

For the Inventor, By the Inventor

Leiden, Netherlands

Janssen Vaccines & Prevention B.v.


USPTO Granted Patents = 115



Trademarks = 2

Forward Citations = 180

Loading Chart...
Loading Chart...

279 inventors (with patents filed for the assignee):

goldMedal Johannes Petrus Maria Langedijk (26 out of 28 patents)

silverMedal Taco Gilles Uil (16 out of 16 patents)

bronzeMedal Selina Khan (12 out of 15 patents)

4.  Jort Vellinga (12 out of 15 patents)

5.  Benoit Christophe Stephan Callendret (11 out of 11 patents)

6.  Jerôme Hubertina Henricus Victor Custers (10 out of 12 patents)

7.  Maria Grazia Pau (10 out of 30 patents)

8.  Katarina Radosevic (10 out of 16 patents)

9.  Ronald Vogels (9 out of 50 patents)

10.  Evelien Margaretha Bunnik (8 out of 8 patents)

11.  Gerrit Christiaan Scheper (8 out of 8 patents)

12.  Koen Oosterhuis (8 out of 8 patents)

13.  Jehangir Wadia (8 out of 13 patents)

14.  Robert Anthony Williamson (8 out of 13 patents)

15.  Jerôme H H V Custers (7 out of 10 patents)


Core Competencies:
Influenza Virus Vaccines
RSV F Proteins
HIV Envelope Proteins
Adenovirus Vectors
Filovirus Infection Immunization
Heterologous RepRNA Immunizations
Poxvirus Vectors
Zika Antigen Expression
Tau Protein Binding Molecules
Immunodeficiency Virus Vaccines
Chromatography Methods
Therapeutic HPV Vaccines

115 patents:

1. 12454554 - Influenza virus vaccines and uses thereof (2025-10-28),
2. 12331077 - Stabilized pre-fusion RSV F proteins (2025-06-17),
3. 12234264 - Stabilized soluble pre-fusion RSV F proteins (2025-02-25),
4. 12054737 - Potent and short promoter for expression of heterologous genes (2024-08-06),
5. 11998597 - Vaccine against RSV (2024-06-04),
6. 11964007 - Methods and compositions for heterologous repRNA immunizations (2024-04-23),
7. 11918639 - Methods and compositions for inducing protective immunity against filovirus infection (2024-03-05),
8. 11905314 - Influenza virus vaccines and uses thereof (2024-02-20),
9. 11896663 - Immunodeficiency virus type 1 (HIV-1) mutant envelope proteins (2024-02-13),
10. 11872281 - Adenovirus and uses thereof (2024-01-16),
11. 11857619 - Multimodal chromatography method for the purification of HIV-1 envelope glycoprotein (2024-01-02),
12. 11820796 - Trimer stabilizing HIV envelope protein mutations (2023-11-21),
13. 11801297 - Vaccine against RSV (2023-10-31),
14. 11781155 - Potent and balanced bidirectional promoter (2023-10-10),
15. 11759514 - Stabilized pre-fusion RSV F proteins (2023-09-19),
JANSSEN VACCINES & PREVENTION B.V. is a leading pharmaceutical company that focuses on the development, production, and commercialization of vaccines and prevention solutions. They are dedicated to addressing pressing global health challenges and improving people's lives through innovative healthcare solutions. Visit their website for more information.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
115 Patents

#2 in

#77 in

#6,683 in the World

...
Leiden, Netherlands

Janssen Vaccines & Prevention B.v.

Forward Citations = 180

279 inventors:

goldMedal Johannes Petrus Maria Langedijk (26 out of 28 patents)

silverMedal Taco Gilles Uil (16 out of 16 patents)

bronzeMedal Selina Khan (12 out of 15 patents)

4.  Jort Vellinga (12 out of 15 patents)

5.  Benoit Christophe Stephan Callendret (11 out of 11 patents)

Please report any incorrect information to support@idiyas.com
Loading…